CellGenTech
Chiba
About CellGenTech
CellGenTech is a Therapeutics Company. CellGenTech is currently exploring opportunities for alliances to advance the development of gene/cell therapy using Pre-Adipocytes Technology. We are now performing the translational clinical research for LCAT deficiency as the 1st target and trying to expand this new therapy to other rare diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.6M
- Last round: Series Unknown (Jan 2021)
- Website: cellgentech.com
- Phone: +81-043-441-4121
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/cellgentech-74387 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.